<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03515603</url>
  </required_header>
  <id_info>
    <org_study_id>EndOSPA</org_study_id>
    <nct_id>NCT03515603</nct_id>
  </id_info>
  <brief_title>Endocrine Outcome of Surgery for Pituitary Adenoma</brief_title>
  <official_title>Compare Between Endoscopic and Microsurgical Transsphenoidal Resection of Pituitary Adenomas With Intraoperative MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective and randomized compare between microsurgical and endoscopic transsphenoidal MRI
      assisted resection of pituitary adenomas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main aim of the study is to compare microsurgical and endoscopic transsphenoidal surgery
      and to determine endocrine outcome. Secondary extent of resection and quality of life will be
      evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective randomized</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>only surgeon knows the used technique, endocrinologist, patient and all involved medical staff is blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>endocrine function</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Testing of pituitary function with insulin-hypoglycemic test, results will be dichotomized as satisfactory or not satisfactory. Satisfactory outcome is defined, if pituitary function improves or is stable, if compared to preoperative testing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extent of resection</measure>
    <time_frame>tumor volume before the surgery, 3 months after surgery</time_frame>
    <description>Volumetric analysis of tumor volume before the surgery, intraoperatively and 3 months after surgery will be performed. Gross total resection is defined as no tumor present in gadolinium enhanced T1 sequences</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>3 months and 1 year after surgery</time_frame>
    <description>EQ-5D will be evaluated before surgery, after the surgery in 3 months and after 1 year.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pituitary Adenoma</condition>
  <arm_group>
    <arm_group_label>microsurgical technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>endoscopic technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic resection</intervention_name>
    <description>Transsphenoidal endoscopic resection of pituitary adenoma</description>
    <arm_group_label>endoscopic technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microsurgical resection</intervention_name>
    <description>Transsphenoidal microsurgical resection of pituitary adenoma</description>
    <arm_group_label>microsurgical technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected symptomatic or progressively growing pituitary adenoma

          -  Informed consent

        Exclusion Criteria:

          -  Prolactinoma

          -  No follow-up possible

          -  Emergency surgery without informed consent or without intraoperative MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrej Pala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Ulm, Department of Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrej Pala, MD</last_name>
    <phone>+4982219628866</phone>
    <email>andrej.pala@uni-ulm.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michal Hlavac, MD</last_name>
    <email>michal.hlavac@uni-ulm.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurosurgery</name>
      <address>
        <city>GÃ¼nzburg</city>
        <zip>89312</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Deininger</last_name>
      <phone>+4982219622504</phone>
      <email>monika.deininger@bkh-guenzburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Andrej Pala, MD</last_name>
      <email>andrej.pala@uni-ulm.de</email>
    </contact_backup>
    <investigator>
      <last_name>Andrej Pala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michal Hlavac, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2018</study_first_submitted>
  <study_first_submitted_qc>May 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Andrej Pala</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Pituitary Diseases</mesh_term>
    <mesh_term>Pituitary Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

